Thank you for answering my inquiries and addressing my poorly asked question apropos HCV and the drugs being developed by IDIX.
It seems to me that IDIX buyout will be much more complicated than I had originally thought as I reviewed your comments-opinion. Time will tell and I am curiously watching how this will all play out.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.